The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
Open accessAbstract
Summary: In June 2005, an ad hoc Expert Committee formed by the Pituitary Society convened during the 9th International Pituitary Congress in San Diego, California. Members of this committee consisted of invited international experts in the field, and included endocrinologists and neurosurgeons with recognized expertise in the management of prolactinomas. Discussions were held that included all interested participants to the Congress and resulted in formulation of these guidelines, which represent the current recommendations on the diagnosis and management of prolactinomas based upon comprehensive analysis and synthesis of all available data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Criteria for Cure of Acromegaly: A Consensus Statement
Giustina, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.526 · Cited by 987
Self-citationA Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea
Webster, J., Piscitelli, G., Polli, A., Ferrari, C. I., Ismail, I., & Scanlon, M. F. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410063311403 · Cited by 699
Self-citationPituitary Disease in MEN Type 1 (MEN1): Data from the France-Belgium MEN1 Multicenter Study
Vergès, B., Boureille, F., Goudet, P., Murat, A., Beckers, A., Sassolas, G., Cougard, P., Chambe, B., Montvernay, C., & Calender, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8145 · Cited by 483
Dopamine Agonists and Pituitary Tumor Shrinkage
BEVAN, J. S., WEBSTER, J., Burke, C. W., & Scanlon, M. F. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-220 · Cited by 469
Self-citationCabergoline in the Treatment of Hyperprolactinemia: A Study in 455 Patients
Verhelst, J., Abs, R., Maiter, D., van den Bruel, A., Vandeweghe, M., Velkeniers, B., Mockel, J., Lamberigts, G., Petrossians, P., Coremans, P., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5810 · Cited by 449
Self-citationMOLITCH, M. E., ELTON, R. L., BLACKWELL, R. E., CALDWELL, B., CHANG, R. J., JAFFE, R., JOPLIN, G., ROBBINS, R. J., TYSON, J., & THORNER, M. O. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-4-698 · Cited by 435
Self-citationWithdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
Colao, A., Di Sarno, A., Cappabianca, P., Di Somma, C., Pivonello, R., & Lombardi, G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022657 · Cited by 336
Self-citationProlactinomas Resistant to Standard Dopamine Agonists Respond to Chronic Cabergoline Treatment
Colao, A. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.3.876 · Cited by 276
Self-citationThe Natural History of Untreated Hyperprolactinemia: A Prospective Analysis*
SCHLECHTE, J., DOLAN, K., SHERMAN, B., CHAPLER, F., & LUCIANO, A. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-2-412 · Cited by 271
Self-citationSchlechte, J. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp025334 · Cited by 258
Self-citationPregnancy and the Hyperprolactinemic Woman
Molitch, M. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505233122106 · Cited by 254
Self-citationMedication-Induced Hyperprolactinemia
Molitch, M. E. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.8.1050 · Cited by 250
Self-citationColao, A., Di Sarno, A., Landi, M. L., Scavuzzo, F., Cappabianca, P., Pivonello, R., Volpe, R., Di Salle, F., Cirillo, S., Annunziato, L., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6657 · Cited by 227
Self-citationEffects of Prolactin and Estrogen Deficiency in Amenorrheic Bone Loss*
KLIBANSKI, A., BILLER, B. M. K., ROSENTHAL, D. I., SCHOENFELD, D. A., & SAXE, V. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-1-124 · Cited by 182
Surgical Treatment of Prolactin-Secreting Pituitary Adenomas: Early Results and Long-Term Outcome
Losa, M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3180 · Cited by 181
Pregnancy outcome after treatment with the ergot derivative, cabergoline
Robert, E., Musatti, L., Piscitelli, G., & Ferrari, C. I. (1996) · Reproductive Toxicology · doi:10.1016/0890-6238(96)00063-9 · Cited by 178
The Impact on Clinical Practice of Routine Screening for Macroprolactin
Gibney, J., Smith, T. P., & McKenna, T. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2234 · Cited by 159
Pregnancy outcome after cabergoline treatment in early weeks of gestation
Ricci, E. D., Parazzini, F., Motta, T., Ferrari, C. I., Colao, A., Clavenna, A., Rocchi, F., Gangi, E., Paracchi, S., Gasperi, M., et al. (2002) · Reproductive Toxicology · doi:10.1016/s0890-6238(02)00055-2 · Cited by 157
Self-citationEffects of Psychiatric Disorders and Psychotropic Medications on Prolactin and Bone Metabolism
Misra, M., Papakostas, G. I., & Klibanski, A. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1205 · Cited by 156
Treatment of macroprolactinoma with cabergoline: a study of 85 patients
Ferrari, C. I., Abs, R., Bevan, J. S., Brabant, G. E., CICCARELLI, E., Motta, T., Mucci, M., Muratori, M., Musatti, L., Verbessem, G., et al. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1300952.x · Cited by 154
Self-citationBromocriptine in pregnancy: Safety aspects
Krupp, P., & Monka, C. (1987) · Journal of Molecular Medicine · doi:10.1007/bf01727477 · Cited by 150
Visual Loss in Pregnant Women with Pituitary Adenomas
Kupersmith, M. J., Rosenberg, C., & Kleinberg, D. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-7-199410010-00001 · Cited by 142
Self-citationHigh prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas
St‐Jean, E., Blain, F., & Comtois, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.663486.x · Cited by 133
Long‐term follow‐up of patients with hyperprolactinaemia
Jeffcoate, W. J., Pound, N., Sturrock, N. D. C., & Lambourne, J. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00824.x · Cited by 129
CURRENT APPROACHES TO IMAGING OF THE SELLAR REGION AND PITUITARY
Naidich, M. J., & Russell, E. J. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70057-8 · Cited by 119
Bevan, J. S., ADAMS, C. B. T., Burke, C. W., MORTON, K. E., Molyneux, A., Moore, A., & Esiri, M. M. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00809.x · Cited by 117
Konopka, P., Raymond, J. P., Merceron, R. E., & Sénèze, J. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90968-7 · Cited by 110
Long-Term Follow-Up of Prolactinomas: Normoprolactinemia after Bromocriptine Withdrawal
Passos, V. Q., de Souza, J. J. S., Musolino, N. R. D. C., & Bronstein, M. D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8722 · Cited by 107
Self-citationMedical Management of Prolactin-Secreting Pituitary Adenomas
Molitch, M. E. (2002) · Pituitary · doi:10.1023/a:1022375429083 · Cited by 104
Self-citationThe effect of the menopause on prolactin levels in patients with hyperprolactinaemia
Karunakaran, S., Page, R. C., & Wass, J. A. H. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01190.x · Cited by 104
Self-citationEFFECT OF DOPAMINE AGONIST WITHDRAWAL AFTER LONG-TERM THERAPY IN PROLACTINOMAS
Johnston, D. G., Taylor, P. K., Watson, M., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90480-x · Cited by 103
Dopamine Resistance of Prolactinomas
Molitch, M. E. (2003) · Pituitary · doi:10.1023/a:1026225625897 · Cited by 102
Self-citationColao, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.6.2247 · Cited by 97
Self-citationPrimary Lymphoma of the Pituitary: An Emerging Clinical Entity
Giustina, A., Gola, M., Doga, M., & Rosei, E. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7909 · Cited by 95
Self-citationCurrent management of prolactinomas
Nomikos, P., Buchfelder, M., & Fahlbusch, R. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1012905415868 · Cited by 94
Self-citationPetakov, M. S., Damjanovic, S. S., Nikolic-Djurovic, M., Dragojlović, Z., Obradović, S., Gligorović, M. S., Simic, M., & Popović, V. P. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03347299 · Cited by 83
Yazigi, R. A., Quintero, C. H., & Salameh, W. A. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81900-0 · Cited by 73
Residual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas
Nelson, A. T., Tucker, H. S. G., & Becker, D. P. (1984) · Journal of neurosurgery · doi:10.3171/jns.1984.61.3.0577 · Cited by 66
Successful Treatment of a Large Macroprolactinoma with Cabergoline During Pregnancy
Liu, C., & Tyrrell, J. (2001) · Pituitary · doi:10.1023/a:1015319007880 · Cited by 61
Long-Term Follow-Up of Prolactinomas: Normoprolactinemia after Bromocriptine Withdrawal
Passos, V. Q. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3578 · Cited by 39
Cited by
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1692 · Cited by 1,844
Self-citationDiagnosis and Treatment of Pituitary Adenomas: A Review
Molitch, M. E. (2017) · JAMA · doi:10.1001/jama.2016.19699 · Cited by 933
Self-citationPituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline
Freda, P. U., Beckers, A. M., Katznelson, L., Molitch, M. E., Montori, V. M., Post, K. D., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1048 · Cited by 585
Self-citationPetersenn, S., Fleseriu, M., Casanueva, F. F., Giustina, A., Biermasz, N., Biller, B. M. K., Bronstein, M., Chanson, P., Fukuoka, H., Gadelha, M., et al. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00886-5 · Cited by 411
Self-citationClinical Biology of the Pituitary Adenoma
Melmed, S., Kaiser, U. B., Lopes, M. B., Bertherat, J., Syro, L. V., Raverot, G., Reincke, M., Johannsson, G., Beckers, A., Fleseriu, M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac010 · Cited by 321
Self-citation
Metadata
- Authors
- Casanueva, F. F., Molitch, M. E., Schlechte, J. A., Abs, R., Bonert, V., Bronstein, M. D., Brue, T., Cappabianca, P., Colao, A., Fahlbusch, R., Fideleff, H., Hadani, M., Kelly, P., Kleinberg, D., Laws, E., Marek, J., Scanlon, M., Sobrinho, L. G., Wass, J. A. H., & Giustina, A.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2006-07-06
- Volume
- 65
- Issue
- 2
- Pages
- 265-273
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2116305496
- Cited by
- 829
- References
- 40
- FWCI
- 14.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.